New Devyser BRCA NGS study published

Hereditary cancer

Hereditary cancer | September 30, 2022

Check out a recent publication from Capone et al from the University of Florence!

In this study, the Devyser BRCA test was used to analyze 227 patient DNA samples. They concluded that 100% of the expected SNVS and CNVS were detected and that the single-tube PCR-based library preparation format of the kit offers a decrease in processing time as well as a reduced risk of cross-contamination.

Read abstract using this link

Contact an expert at Devyser

If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.

New Devyser BRCA NGS study published

Contact an expert at Devyser

Health Canada grants IVD approval to Devyser’s NGS-based chimerism test, the first of its kind in Canada

Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test

Devyser advances U.S. clinical strategy with first patient enrolled in Devyser Accept cfDNA study

Devyser CFTR achieves IVDR compliance, strengthening clinical confidence in cystic fibrosis diagnostics

New Devyser BRCA NGS study published

Contact an expert at Devyser

Related Articles

Health Canada grants IVD approval to Devyser’s NGS-based chimerism test, the first of its kind in Canada

Devyser strengthens U.S. market presence with CMS pricing for PrenatalDetect RHD test

Devyser advances U.S. clinical strategy with first patient enrolled in Devyser Accept cfDNA study

Devyser CFTR achieves IVDR compliance, strengthening clinical confidence in cystic fibrosis diagnostics